Frazier Lifesciences Acquisition Corp

CIK 1828326 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Frazier Lifesciences Acquisition Corp.

Recent SEC filings

FiledFormAccession number
Feb 14, 2023SC 13G/A0001172661-23-001218
Dec 2, 202215-12G0001193125-22-297570
Dec 1, 2022SC 13G/A0001193805-22-001629
Nov 25, 2022SC 13D/A0001140361-22-043112
Nov 25, 202240001140361-22-043107
Nov 23, 2022SC 13D/A0001193125-22-292025
Nov 23, 202240000899243-22-036924
Nov 23, 202240000899243-22-036923
Nov 23, 202240000899243-22-036925
Nov 23, 20228-K0001193125-22-292061
Nov 23, 202240000899243-22-036936
Nov 23, 202240000899243-22-036927
Nov 22, 202225-NSE0001354457-22-000662
Nov 22, 202225-NSE0001354457-22-000660
Nov 22, 202225-NSE0001354457-22-000661
Nov 16, 20224250001193125-22-286672
Nov 15, 20228-K0001193125-22-285506
Nov 14, 202230001193805-22-001540
Nov 14, 2022SC 13G0001193805-22-001532
Nov 9, 202210-Q0001193125-22-281196
Nov 4, 202240001140361-22-040057
Nov 4, 202230001140361-22-040054
Nov 3, 2022SC 13D0001140361-22-039877
Nov 2, 2022SC 13G0001140361-22-039468
Oct 18, 2022DEFM14A0001193125-22-264485